Ameritas Investment Partners Inc. Grows Holdings in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

Ameritas Investment Partners Inc. boosted its position in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) by 5.5% during the first quarter, Holdings Channel.com reports. The fund owned 11,200 shares of the company’s stock after acquiring an additional 587 shares during the quarter. Ameritas Investment Partners Inc.’s holdings in First Trust Nasdaq Pharmaceuticals ETF were worth $314,000 as of its most recent filing with the Securities and Exchange Commission.

Separately, Janney Montgomery Scott LLC bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 1st quarter valued at $1,030,000.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

Shares of First Trust Nasdaq Pharmaceuticals ETF stock opened at $28.46 on Thursday. The company has a market capitalization of $18.50 million, a P/E ratio of 15.98 and a beta of 0.70. The company has a fifty day moving average of $27.25 and a 200 day moving average of $27.22. First Trust Nasdaq Pharmaceuticals ETF has a fifty-two week low of $23.85 and a fifty-two week high of $28.72.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, June 28th. Shareholders of record on Thursday, June 27th were paid a $0.1284 dividend. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.07. The ex-dividend date of this dividend was Thursday, June 27th.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.